Ramírez CE, Saucedo MEE, Arenas GR, Solórzano SF

Language: Spanish
References: 13
Page: 28-35
PDF size: 471.20 Kb.

ABSTRACT

Onychomycosis is the fungal infection of any of the elements of the nail apparatus (lamina, bed or nail matrix) produced by dermatophytes, yeasts and other opportunistic fungal species. It is a recurrent chronic infection. Onychomycosis in children is less common than in adults, with an average frequency less than 2%. Diagnosis is made by clinical suspicion and the mycological confirmation through direct examination with potassium hydroxide (KOH) or clorazol black from the scales of the nails.
A review of the main characteristics of this pathology is presented and the main treatment alternatives are described.

REFERENCES

1. Solís-Arias, M.P. y García-Romero, M.T., “Onychomycosis in children. A review”, Int J Dermatol, 2017, 56 (2): 123-130.

2. Li, D.G., Cohen, J.M., Mikailov, A., Williams, R.F., Laga, A.C. y Mostaghimi, A., “Clinical diagnostic accuracy of onychomycosis: a multispecialty comparison study”, Dermatol Res Pract, 2018, 2018: 2630176.

3. Vásquez del Mercado, E. y Arenas, R., “Datos epidemiológicos y etiológicos de las micosis superficiales en los niños de un servicio de dermatología de la Ciudad de México”, Dermatología Rev Mex, 2004, 48: 295-299.

4. Asz-Sigall, D., Tosti, A. y Arenas, R., “Tinea unguium: diagnosis and treatment in practice”, Mycopathologia, 2017, 182 (1-2): 95-100.

5. Arenas, R., “Las onicomicosis. Aspectos clínico-epidemiológicos, micológicos y terapéuticos”, Gac Med Mex, 1990, 126 (2): 84-91.

6. Ruiz-Esmenjaud, J., Arenas, R., Rodríguez-Álvarez, M., Monroy, E. y Felipe Fernández, R., “Tinea pedis and ony- chomycosis in children of the Mazahua indian community in Mexico”, Gac Med Mex, 2003, 139 (3): 215-220.

7. Sav, H., Baris, A., Turan, D., Altinbas, R. y Sen, S., “The frequency, antifungal susceptibility and enzymatic profiles of Candida species in cases of onychomycosis infection”, Microb Pathog, 2018, 116: 257-262.

8. Martínez-Herrera, E.O., Arroyo-Camarena, S., Tejada-García, D.L., Porras-López, C.F. y Arenas, R., “Onychomycosis due to opportunistic molds”, An Bras Dermatol, 2015, 90 (3): 334-337.

9. Saunte, D.M.L., Piraccini, B.M., Sergeev, A.Y., Prohić, A., Sigurgeirsson, B., Rodríguez-Cerdeira, C. et al., “A survey among dermatologists: diagnostics of superficial fungal infections: what is used and what is needed to initiate therapy and assess efficacy?”, J Eur Acad Dermatol Venereol, 2018, 23 de noviembre, doi: 10.1111/jdv.15361. [Epub ahead of print].

10. Gupta, A.K., Versteeg, S.G. y Shear, N.H., “Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment”, J Cutan Med Surg, 2017, 21 (6): 525-539.

11. Yang, E.J. y Lipner, S.R., “Pharmacy costs of medications for the treatment of onychomycosis in the United States”, J Am Acad Dermatol, 2019, 25 de enero, pii: S0190-9622(19)30138-0.

12. Kreijkamp-Kaspers, S., Hawke, K., Guo, L., Kerin, G., Bell- Syer, S.E., Magin, P., Bell-Syer, S.V. y Van Driel, M.L., “Oral antifungal medication for toenail onychomycosis”, Cochrane Database Syst Rev, 2017, 14 de julio, 7:CD010031.

13. Werschler, W.P., Smith, A.S. y Bondar, G.L., “Treatment of onychomycosis in the elderly”, Clinical Geriatrics, 2002, 10: 19-30.